Walter Birkmayer
Affiliations: | Neurochemie | Ludwig Boltzmann Gesellschaft |
Google:
"Walter Birkmayer"Mean distance: (not calculated yet)
Children
Sign in to add trainee| Peter Franz Riederer | research scientist | Ludwig Boltzmann Gesellschaft |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Birkmayer W, Hornykiewicz O. (2001) The effect of l-3,4-dihydroxyphenylalanine (= DOPA) on akinesia in parkinsonism. 1961. Wiener Klinische Wochenschrift. 113: 851-4 |
| Birkmayer W, Hornykiewicz O. (1998) The effect of l-3,4-dihydroxyphenylalanine (=DOPA) on akinesia in parkinsonism. Parkinsonism & Related Disorders. 4: 59-60 |
| Birkmayer GJ, Birkmayer W. (1989) Stimulation of endogenous L-dopa biosynthesis--a new principle for the therapy of Parkinson's disease. The clinical effect of nicotinamide adenine dinucleotide (NADH) and nicotinamide adenine dinucleotidephosphate (NADPH). Acta Neurologica Scandinavica. Supplementum. 126: 183-7 |
| Birkmayer W, Birkmayer JD. (1987) Dopamine action and disorders of neurotransmitter balance. Gerontology. 33: 168-71 |
| Birkmayer W, Riederer P. (1986) Biological aspects of depression in Parkinson's disease. Psychopathology. 19: 58-61 |
| Birkmayer W, Knoll J, Riederer P, et al. (1985) Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: a longterm study. Journal of Neural Transmission. 64: 113-27 |
| Birkmayer W, Riederer P, Linauer W, et al. (1984) L-deprenyl plus L-phenylalanine in the treatment of depression. Journal of Neural Transmission. 59: 81-7 |
| Birkmayer W, Riederer P. (1984) Deprenyl prolongs the therapeutic efficacy of combined L-DOPA in Parkinson's disease. Advances in Neurology. 40: 475-81 |
| Birkmayer W, Birkmayer G, Lechner H, et al. (1983) DL-3,4-threo-DOPS in Parkinson's disease: effects on orthostatic hypotension and dizziness. Journal of Neural Transmission. 58: 305-13 |
| Birkmayer W, Knoll J, Riederer P, et al. (1983) (-)-Deprenyl leads to prolongation of L-dopa efficacy in Parkinson's disease. Modern Problems of Pharmacopsychiatry. 19: 170-6 |